Lord, Abbett & Co
TECH icon

Lord, Abbett & Co’s Bio-Techne TECH Stock Holding History

Lord, Abbett & Co’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.4M Sell
289,060
-2,055
-0.7% -$111K 0.06% 306
2026
Q1 		$15.2M Sell
291,115
-6,248
-2% -$375K 0.05% 311
2025
Q4 		$17.5M Buy
297,363
+36,509
+14% +$2.22M 0.05% 303
2025
Q3 		$14.5M Sell
260,854
-19,676
-7% -$1.05M 0.04% 329
2025
Q2 		$14.4M Sell
280,530
-11,046
-4% -$555K 0.05% 334
2025
Q1 		$17.1M Sell
291,576
-3,124
-1% -$212K 0.06% 305
2024
Q4 		$21.2M Sell
294,700
-2,124
-0.7% -$156K 0.07% 315
2024
Q3 		$23.7M Sell
296,824
-36,339
-11% -$2.73M 0.08% 309
2024
Q2 		$23.9M Buy
333,163
+54,695
+20% +$4.03M 0.08% 292
2024
Q1 		$19.6M Buy
278,468
+17,288
+7% +$1.24M 0.06% 335
2023
Q4 		$20.2M Sell
261,180
-2,235
-0.8% -$147K 0.07% 336
2023
Q3 		$17.9M Buy
263,415
+1,316
+0.5% +$104K 0.07% 340
2023
Q2 		$21.4M Sell
262,099
-67,753
-21% -$5.45M 0.07% 335
2023
Q1 		$24.5M Sell
329,852
-2,600
-0.8% -$200K 0.09% 317
2022
Q4 		$27.6M Buy
332,452
+23,412
+8% +$1.86M 0.1% 282
2022
Q3 		$21.9M Buy
309,040
+2,004
+0.7% +$173K 0.08% 315
2022
Q2 		$26.6M Buy
307,036
+576
+0.2% +$54K 0.09% 285
2022
Q1 		$33.2M Sell
306,460
-78,388
-20% -$8.09M 0.09% 290
2021
Q4 		$49.8M Buy
384,848
+6,476
+2% +$794K 0.11% 263
2021
Q3 		$45.8M Sell
378,372
-18,924
-5% -$2.3M 0.11% 276
2021
Q2 		$44.7M Buy
397,296
+25,932
+7% +$2.73M 0.11% 280
2021
Q1 		$35.5M Sell
371,364
-25,236
-6% -$2.3M 0.09% 323
2020
Q4 		$31.5M Sell
396,600
-11,200
-3% -$811K 0.08% 342
2020
Q3 		$25.3M Sell
407,800
-15,200
-4% -$989K 0.08% 338
2020
Q2 		$27.9M Buy
423,000
+2,412
+0.6% +$144K 0.1% 321
2020
Q1 		$19.9M Sell
420,588
-2,892
-0.7% -$145K 0.09% 324
2019
Q4 		$23.2M Sell
423,480
-115,672
-21% -$6.07M 0.08% 367
2019
Q3 		$26.4M Buy
539,152
+494,868
+1,117% +$24.8M 0.09% 354
2019
Q2 		$2.31M Buy
+44,284
New +$2.23M 0.01% 698
2018
Q4 		– Sell
-1,344,992
Closed -$68.6M – 826
2018
Q3 		$68.6M Sell
1,344,992
-182,544
-12% -$8.09M 0.19% 162
2018
Q2 		$56.5M Buy
1,527,536
+242,032
+19% +$9.24M 0.17% 205
2018
Q1 		$48.5M Buy
1,285,504
+7,816
+0.6% +$276K 0.14% 221
2017
Q4 		$41.4M Sell
1,277,688
-29,764
-2% -$946K 0.12% 278
2017
Q3 		$39.5M Sell
1,307,452
-1,644
-0.1% -$48.8K 0.12% 284
2017
Q2 		$38.5M Buy
1,309,096
+446,516
+52% +$12.2M 0.11% 281
2017
Q1 		$21.9M Buy
862,580
+297,236
+53% +$7.67M 0.07% 426
2016
Q4 		$14.5M Sell
565,344
-388,248
-41% -$10.2M 0.04% 489
2016
Q3 		$26.1M Sell
953,592
-293,872
-24% -$8.07M 0.08% 378
2016
Q2 		$35.2M Buy
+1,247,464
New +$32.1M 0.11% 302

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Lord, Abbett & Co's TECH Position: Q2 2026 in Review

Lord, Abbett & Co reduced its Bio-Techne (TECH) stake by 0.71% in Q2 2026, selling an estimated $111K and leaving 289,060 shares worth $20.4M. The position accounts for 0.06% of the portfolio, ranked #306.

Lord, Abbett & Co first reported a position in TECH in Q2 2016 and has held it in 39 quarters since. The position peaked at $68.6M in Q3 2018. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Lord, Abbett & Co held 289,060 shares of Bio-Techne worth $20.4M as of Q2 2026.
  • Lord, Abbett & Co sold 2,055 Bio-Techne shares in Q2 2026, an estimated $111K.
  • Bio-Techne made up 0.06% of Lord, Abbett & Co's portfolio in Q2 2026, its #306 holding.
  • Lord, Abbett & Co first reported a position in Bio-Techne in Q2 2016 and has held it in 39 quarters since.
  • Lord, Abbett & Co's Bio-Techne position peaked at $68.6M in Q3 2018.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Lord, Abbett & Co's 13F filing for Q2 2026, filed 14 Aug 2026.